IVD Quality Control Product Market Overview:
Global IVD Quality Control Products Market was valued at $823 million in 2015, and is expected to reach $1,052 million by 2022, supported by a CAGR of 3.5% during the forecast period 2014 - 2022. IVD quality controls are samples/materials used to validate the reliability of IVD testing system to ensure accuracy of test results and evaluate the impact of factors such as environmental conditions and operators performance on test results. This is attributed to upsurge in demand for third-party quality controls, increase in the number of accredited clinical laboratories, and stringent mandates from accreditation bodies & regulatory agencies regarding the use of controls. Poor reimbursement policies and stringent regulatory norms are expected to hamper the market growth during the analysis period.
Global In Vitro Diagnostics (IVD) Quality Controls Market: Segmentation
The global In Vitro Diagnostics quality controls market is segmented on the basis of product type, application, manufacturer type, end user, and region. Based on product type, the market is segmented into quality controls, IVD quality control data management software, and quality assurance services. The quality controls segment dominated the global market by product type in 2015, and is expected to maintain its dominance by 2022, registering the fastest CAGR of 3.7% during the forecast period. This is attributed to the upsurge in demand for quality controls to validate the accuracy, precision, and reliability of IVD test results.
The end users of the market include hospitals, clinical laboratories, research & academic institutes, and others. The hospital segment dominated the IVD quality controls market in 2015, and is expected to maintain its dominance during the forecast period. Based on the manufacturer, the market is bifurcated into instrument manufacturer controls and independent manufacturer controls including third-party controls and instrument specific controls. The independent manufacturer controls segment accounted for the major share of the market in 2015, and is projected to grow at the fastest CAGR during the forecast period, owing to increase in demand for multianalyte and third party controls.
Top Investment Pockets: In Vitro Diagnostics (IVD) Quality Controls Market
The application areas of the In Vitro Diagnostics quality controls market include immunochemistry, clinical chemistry, hematology, molecular diagnostics, coagulation, microbiology, and others. The immunochemistry application segment dominated the global IVD quality controls market by application in 2015, and is estimated to maintain this dominance during the analysis period, owing to rise in demand for high-sensitivity immunochemistry tests, and increase in availability of multianalyte controls to validate the accuracy of immunoassay test menus. However, the molecular diagnostics segment is projected to grow at the fastest CAGR of 5.3% during the forecast period, owing to increase in the number of molecular diagnostic tests performed across the globe due to increased acceptance for personalized medicines.
The global IVD quality control market is segmented into four regions, which include North America, Europe, Asia-Pacific, and LAMEA. The North America dominated the global IVD quality controls market in 2015, and is expected to continue its dominance during the forecast period, owing to increase in demand for technologically advanced multianalyte controls and stringent mandates for using controls. However, Asia-Pacific and LAMEA regions are estimated grow at significant CAGRs of 4.9% and 4.1%, respectively, during the forecast period due to growing number of accredited laboratories in the region and increasing volume of IVD tests performed in the region. In addition, countries such as China, India offer significant growth opportunities for market players due to upsurge in the number of hospitals and clinical pathologies, improvement in healthcare infrastructure, and rise in heath awareness.
China IVD Quality Control Products Market Size, 2014-2022 ($Million)
The key players profiled in the IVD quality controls market report are Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Randox Laboratories Ltd., Roche Diagnostics, Abbott Diagnostics, Helena Laboratories, Seracare Life Sciences, Inc., Technopath Clinical Diagnostics, and Sun Diagnostics, LLC.
The other prominent players in the IVD quality controls industry (not profiled in the report) are Zeptometrix Corporation, ISOLAB GmbH, Sysmex Corporation, Fortress Diagnostics, Meril Life Sciences Pvt. Ltd., Multiplicom N.V., Future Diagnostics Solutions B.V., and Surmodics, Inc.
KEY MARKET BENEFITS
- In-depth analysis of the IVD quality controls market is based on market estimations of key segments for the period of 20142022.
- Comprehensive analysis of factors that drive and restrict the market growth of IVD quality controls industry is provided in the report.
- Exhaustive analysis of IVD quality controls industry market segments aids in understanding the prospects of IVD quality control products that are presently in use as well as with variants that would gain prominence in the future.
- Competitive intelligence of leading manufacturers and distributors helps in interpreting the competitive scenario of geographies.
- The profiles and strategies of key market players are thoroughly analyzed in the report to understand the competitive outlook of the market.
KEY MARKET SEGMENTS
BY PRODUCT TYPE
- Quality Controls
- Whole Blood-based Controls
- Serum/Plasma-based Controls
- Urine-based Controls
- Other IVD Quality Controls
- Data Management Solutions
- Quality Assurance Services
- Clinical Chemistry
- Molecular Diagnostics
BY END USER
- Clinical Laboratories
- Research and Academic Institutes
BY MANUFACTURER TYPE
- Instrument Manufacturer Controls
- Independent Manufacturer Controls
- Third-party Controls
- Instrument Manufacturer Controls
- North America
- Rest of Europe
- Rest of Asia-Pacific
- Latin America
- Middle East